Stay updated on Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial

Sign up to get notified when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T14:48:35.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the study record content with an error message and basic site chrome. This indicates access is blocked rather than a substantive content update.
    Difference
    20%
    Check dated 2026-09-21T22:44:11.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Version updated from v3.6.5 to v3.6.6, indicating a minor maintenance patch to the page. No study content or functionality changes are indicated by the provided data.
    Difference
    0.0%
    Check dated 2026-08-31T17:07:32.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A funding attribution line indicating NIH support was added to the study's identifiers. This addition provides provenance about funding for the trial.
    Difference
    0.0%
    Check dated 2026-08-24T17:08:23.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Three new publications were added to the Publications section, including comparative studies of efanesoctocog alfa versus emicizumab and versus standard/extended half-life FVIII, and a patient-satisfaction study from XTEND-1. These entries expand the peer-reviewed context for XTEND-1 without changing how the study is conducted or reported.
    Difference
    0.1%
    Check dated 2026-08-17T13:57:16.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page adds a new release note: Revision: v3.6.5. Several minor footer/meta items are removed, including the EFC16293 Plain Language Results Summary, the Sanofi attribution line, the 'Helpful Links Provided by' section, and the older Revision: v3.6.4 reference, indicating a page cleanup.
    Difference
    0.1%
    Check dated 2026-08-10T10:30:08.000Z thumbnail image

Stay in the know with updates to Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.